These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2325830)

  • 21. The neutral endopeptidase-24.11 inhibitor SCH 34826 does not change opioid binding but reduces D1 dopamine receptors in rat brain.
    Trampus M; Ongini E; Varani K; Borea PA
    Eur J Pharmacol; 1991 Feb; 194(1):17-23. PubMed ID: 1647961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of systemic atropine sulfate administration on the frequency content of the cat sensorimotor EEG during sleep and waking.
    Szymusiak R; McGinty D; Shouse MN; Shepard D; Sterman MB
    Behav Neurosci; 1990 Feb; 104(1):217-25. PubMed ID: 2317279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oxolinic acid on the sleep-wakefulness cycle of the rat.
    D'Angelo L; Monti JM
    Br J Pharmacol; 1981 Oct; 74(2):399-404. PubMed ID: 7317689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of nonsedating histamine H1-antagonists on EEG activity and behavior in the cat.
    Marzanatti M; Monopoli A; Trampus M; Ongini E
    Pharmacol Biochem Behav; 1989 Apr; 32(4):861-6. PubMed ID: 2572005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acute delta 9-THC administration on EEG and EEG power spectra in the rat.
    Buonamici M; Young GA; Khazan N
    Neuropharmacology; 1982 Aug; 21(8):825-9. PubMed ID: 6289162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis.
    Santucci V; Storme JJ; Soubrié P; Le Fur G
    Life Sci; 1996; 58(6):PL103-10. PubMed ID: 8569415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diurnal differences in L-tryptophan sleep and temperature effects in the rat.
    Olsen OE; Neckelmann D; Ursin R
    Behav Brain Res; 1994 Dec; 65(2):195-203. PubMed ID: 7718152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does para-chlorophenylalanine produce disturbed waking, disturbed sleep or activation by ponto-geniculo-occipital waves in cats?
    Ursin R
    Waking Sleeping; 1980; 4(3):211-21. PubMed ID: 6456599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of adenosine and 2'-deoxycoformycin on sleep and wakefulness in rats.
    Virus RM; Djuricic-Nedelson M; Radulovacki M; Green RD
    Neuropharmacology; 1983 Dec; 22(12A):1401-4. PubMed ID: 6607425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholinergic regulation of the central nucleus of the amygdala in rats: effects of local microinjections of cholinomimetics and cholinergic antagonists on arousal and sleep.
    Sanford LD; Yang L; Tang X; Dong E; Ross RJ; Morrison AR
    Neuroscience; 2006 Sep; 141(4):2167-76. PubMed ID: 16843604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioid inhibition of rapid eye movement sleep by a specific mu receptor agonist.
    Cronin A; Keifer JC; Baghdoyan HA; Lydic R
    Br J Anaesth; 1995 Feb; 74(2):188-92. PubMed ID: 7696070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphine effects in brainstem-transected cats: I. EEG and 'sleep-wakefulness' in the isolated forebrain.
    Corpas I; de Andrés I
    Behav Brain Res; 1991 Jul; 44(1):11-9. PubMed ID: 1910566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of beta-endorphin and morphine on the sleep-wakefulness behavior of cats.
    King C; Masserano JM; Codd E; Byrne WL
    Sleep; 1981 Sep; 4(3):259-62. PubMed ID: 6272385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-frequency gamma electroencephalogram activity in association with sleep-wake states and spontaneous behaviors in the rat.
    Maloney KJ; Cape EG; Gotman J; Jones BE
    Neuroscience; 1997 Jan; 76(2):541-55. PubMed ID: 9015337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of ICV administration of neurotensin and analogs on EEG in rats.
    Castel MN; Stutzmann JM; Lucas M; Lafforgue J; Blanchard JC
    Peptides; 1989; 10(1):95-101. PubMed ID: 2748429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of a GABA(B) and GABA(C) receptor antagonist on sleep-waking cycle in the rat.
    Deschaux O; Froestl W; Gottesmann C
    Eur J Pharmacol; 2006 Mar; 535(1-3):177-81. PubMed ID: 16540106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of morphine-induced EEG and behavioral effects by dynorphin A-(1-13) in non-tolerant and morphine-tolerant rats.
    Hong O; Young GA; Khazan N
    Neuropharmacology; 1988 Aug; 27(8):807-12. PubMed ID: 2905786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of MK-801 and sleep deprivation effects on NREM, REM, and waking spectra in the rat.
    Campbell IG; Feinberg I
    Sleep; 1999 Jun; 22(4):423-32. PubMed ID: 10389218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The action of lithium carbonate on the sleep-waking cycle in the cat.
    Lanoir J; Lardennois D
    Electroencephalogr Clin Neurophysiol; 1977 May; 42(5):676-90. PubMed ID: 67027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.